| Literature DB >> 30833347 |
Dallas A Banks1, Sarah E Ahlbrand1, V Keith Hughitt1,2, Swati Shah1, Katrin D Mayer-Barber3, Stefanie N Vogel4, Najib M El-Sayed1,2, Volker Briken5.
Abstract
The type I IFNs (IFN-α and -β) are important for host defense against viral infections. In contrast, their role in defense against nonviral pathogens is more ambiguous. In this article, we report that IFN-β signaling in murine bone marrow-derived macrophages has a cell-intrinsic protective capacity against Mycobacterium tuberculosis via the increased production of NO. The antimycobacterial effects of type I IFNs were mediated by direct signaling through the IFN-α/β-receptor (IFNAR), as Ab-mediated blocking of IFNAR1 prevented the production of NO. Furthermore, M. tuberculosis is able to inhibit IFNAR-mediated cell signaling and the subsequent transcription of 309 IFN-β-stimulated genes in a dose-dependent way. The molecular mechanism of inhibition by M. tuberculosis involves reduced phosphorylation of the IFNAR-associated protein kinases JAK1 and TYK2, leading to reduced phosphorylation of the downstream targets STAT1 and STAT2. Transwell experiments demonstrated that the M. tuberculosis-mediated inhibition of type I IFN signaling was restricted to infected cells. Overall, our study supports the novel concept that M. tuberculosis evolved to inhibit autocrine type I IFN signaling to evade host defense mechanisms.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30833347 PMCID: PMC6456408 DOI: 10.4049/jimmunol.1801303
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422